Goosehead Insurance (GSHD)
(Delayed Data from NSDQ)
$55.50 USD
+2.34 (4.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $55.52 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$55.50 USD
+2.34 (4.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $55.52 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Zacks News
Goosehead (GSHD) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Goosehead (GSHD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Everest Group (EG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Everest Group (EG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MURGY or GSHD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Goosehead Insurance (GSHD) Earnings Expected to Grow: What to Know Ahead of Q1 Release
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Goosehead Insurance (GSHD) Stock?
by Zacks Equity Research
Investors need to pay close attention to Goosehead Insurance (GSHD) stock based on the movements in the options market lately.
MURGY vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
MURGY vs. GSHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
MURGY or GSHD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Goosehead (GSHD) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Goosehead (GSHD) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Goosehead Insurance (GSHD) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -12.50% and 7.57%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to Goosehead (GSHD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Goosehead (GSHD) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Corebridge Financial (CRBG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Corebridge (CRBG) delivered earnings and revenue surprises of 5.05% and 38.08%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRU vs. GSHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PRU vs. GSHD: Which Stock Is the Better Value Option?
AIZ vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
AIZ vs. GSHD: Which Stock Is the Better Value Option?
Here's Why EverQuote (EVER) Shares Are Attracting Investors Now
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performances of home and renters' insurance, and enhanced capital efficiencies.
Why Old Republic (ORI) Shares Are Attracting Investors Now
by Zacks Equity Research
Old Republic (ORI) stands to gain from higher premiums in commercial auto, financial indemnity and property coverages, and a solid balance sheet.
Aegon (AEG) Plans to Repurchase Shares From Vereniging Aegon
by Zacks Equity Research
Aegon (AEG) enters into an agreement with its majority shareholder, Vereniging Aegon, to participate in a share buyback program.
EG vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
EG vs. GSHD: Which Stock Is the Better Value Option?
MGIC Investment (MTG) Up 33.2% in a Year: Will the Rally Last?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of higher insurance in force, a decline in loss and claims payments, better housing market fundamentals and prudent capital deployment.
Radian Group (RDN) Up 39.8% in a Year: More Room for Growth?
by Zacks Equity Research
Radian Group (RDN) stock rallies on the back of improved persistency and mortgage insurance portfolio, robust capital position as well as prudent capital deployment.
Earnings Estimates Moving Higher for Goosehead (GSHD): Time to Buy?
by Zacks Equity Research
Goosehead (GSHD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Retain EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performance of home and renters' insurance and enhanced capital efficiencies.
Goosehead (GSHD) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Goosehead (GSHD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Goosehead (GSHD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Goosehead (GSHD) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.